glp-1 dizziness Hypotension-related events increased after initiation of GLP-1s in patients taking multiple antihypertensive medications, researchers found. Patients aged 65 years or older and those with type 2 diabetes were most at risk. “Hypotension GLP-1 Drugs Linked to Dizziness

In exercise physiology research, IGF1 LR3 provides a tool for studying the cell-level mechanisms underlying muscle adaptation to training

GLP-1 drugs are often reserved for those who need additional help with substantial weight loss

Cagrilintide is a long-acting amylin analogue peptide that has been studied in metabolic research, particularly in models and clinical trials evaluating appetite regulation and body weight

GLP-1 medications are ideal for individuals with a body mass index (BMI) of 30 or higher, which is classified as obese, or a BMI of 27 or higher when accompanied by a weight-related medical condition

Its not clear whether GLP-1 drugs offer extra heart protection beyond weight loss alone in people with normal labs

a study found that industrial-grade mineral oil may be comedogenic but cosmetic-grade mineral oil is not (these two are very, very different)